Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Celiac Disease in Adult South Indian Patients with Diarrhoea Dominant Irritable Bowel Syndrome
 
Avinash Bhat Balekuduru1, Vinusha Reddy2, Satyaprakash Bonthala Subbaraj1, Sanjay. V. Kulkarni
1Department of Gastroenterology, 2Department of General Medicine, Ramaiah Medical College, Bengaluru, Karnataka-54. India.


Corresponding Author
:
Dr Avinash Bhat Balekuduru
Email: avinashbalekuduru@gmail.com


Abstract

Aim & Objectives of the Study: There is paucity of data of prevalence of Celiac disease (CD) in South Indians. Our aim was to study the proportion of CD among patients presenting with diarrhoea dominant irritable bowel syndrome (IBS-D).
Material and Methods: From September 2013 to August 2015, 110 adult IBS –D and 100 age and sex matched controls with functional dyspepsia (FD) were recruited in the prospective cross sectional study done at Ramaiah hospitals, Bangalore. FD and IBS-D were diagnosed based on ROME III criteria. CD was diagnosed by modified ESPGAN criteria. Serum IgA anti tissue transglutaminase (Ig A anti- tTG) antibodies were measured and  esophagogastroduodenoscopy with duodenal biopsies  were performed in all the patients. The study was approved by the institutional ethical committee. 
Results: CD was diagnosed in 2 (1.8%) of 110 IBS-D and 1 (1 %) of 100 FD group. Mean age of the patients 39.4±2.6 (Range-18- 65 years). IgA anti-tTG antibodies were positive in 4 in IBS –D and 2 in control group. Duodenal biopsy showed features of CD in 3- modified marsh grading of III in 2 IBS-D and II in 1 control groups. All patients improved symptomatically on gluten free diet.
Conclusions: CD in the present study was noted in 1.8% in IBS-D and 1% in FD group. Larger screening programs involving different regions are needed for estimating true CD prevalence.